Topics:

AbbVie's Skyrizi Approved, Brooke Shields Endorses SculpSure

Skyrizi, an interleukin-23 inhibitor from AbbVie, is FDA approved for the treatment of moderate to severe plaque psoriasis in adults. Brooke Shields is the face of the new “Be strong. Be sexy. Be confident” campaign for SculpSure, from Hologic’s Cynosure. The Noah Worcester Dermatological Society annual meeting brought members to Palm Springs, CA, for its 61st Annual Meeting. Robert T. Brodell, MD is an American Academy of Dermatology Patient Care Hero, recognized for working with colleagues at the University of Mississippi Medical Center in Oxford to open a dermatology clinic in the Delta.